Aileron Therapeutics, Inc.

NasdaqCM:ALRN Stock Report

Market Cap: US$45.7m

Aileron Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ALRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 24BuyUS$898James WindsorIndividual400US$2.25
17 Jun 24SellUS$21,568The University of Texas/Texas A&M Investment Management CompanyCompany6,607US$3.30
12 Jun 24SellUS$80,707The University of Texas/Texas A&M Investment Management CompanyCompany24,670US$3.35
12 Jun 24SellUS$3The University of Texas/Texas A&M Investment Management CompanyCompany1US$3.28
07 Jun 24SellUS$40,528The University of Texas/Texas A&M Investment Management CompanyCompany12,315US$3.30
01 May 24SellUS$85,473The University of Texas/Texas A&M Investment Management CompanyCompany20,315US$4.32

Insider Trading Volume

Insider Buying: ALRN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ALRN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders258,8161.19%
VC/PE Firms1,983,6639.16%
Institutions4,163,96419.2%
General Public15,259,49870.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 343.5%.

Top Shareholders

Top 25 shareholders own 29.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.16%
Bios Equity Partners LP
1,983,663US$4.2m0%3.95%
4.42%
The University of Texas/Texas A&M Investment Management Company
958,495US$2.0m-31.7%0.31%
2.49%
Alyeska Investment Group, L.P.
540,000US$1.1m0%0.01%
2.14%
Nantahala Capital Management, LLC
464,367US$979.8k0%0.07%
1.99%
The Vanguard Group, Inc.
432,201US$911.9k-14.6%no data
1.94%
Cable Car Capital LLC
420,000US$886.2k0%0.98%
1.72%
Prosight Management, LP
372,157US$785.3k40.4%0.19%
1.07%
Senvest Management, LLC
230,895US$487.2k0%0.01%
1.06%
Geode Capital Management, LLC
229,817US$484.9k34.8%no data
0.98%
Sigma Planning Corporation
212,410US$448.2k68.3%0.01%
0.52%
Muneer Satter
112,800US$238.0k0%no data
0.5%
Leslie Kreis
107,819US$227.5k0%no data
0.33%
Gagnon Securities, LLC
71,761US$151.4k89%0.03%
0.24%
BlackRock, Inc.
51,280US$108.2k63.9%no data
0.12%
Texas Capital Bank Wealth Management Services, Inc.
26,171US$55.2k0%no data
0.12%
Northern Trust Global Investments
25,763US$54.4k0%no data
0.12%
William Blair Investment Management, LLC
25,602US$54.0k-8.72%no data
0.12%
Newbridge Financial Services Group, Inc.
25,000US$52.8k0%0.02%
0.1%
Josef von Rickenbach
22,273US$47.0k0%no data
0.061%
Renaissance Technologies LLC
13,164US$27.8k-47.1%no data
0.06%
KG&L Capital Management, LLC
13,000US$27.4k0%0.01%
0.048%
State Street Global Advisors, Inc.
10,404US$22.0k0%no data
0.046%
Warberg Asset Management LLC
10,000US$21.1k-68.1%0.09%
0.044%
Wells Fargo & Company, Securities and Brokerage Investments
9,544US$20.1k0%no data
0.037%
Royal Bank of Canada, Banking & Securities Investments
8,000US$16.9k-86.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 03:58
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aileron Therapeutics, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ying HuangBofA Global Research
Brian Kemp DolliverBrookline Capital Markets
John NewmanCanaccord Genuity